|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$746,879
|
$448,128
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$1,959
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$1,999
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$37,794
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Workshops On Viral Oncogenesis and Pathogenesis
|
2R13CA095919-09
|
$5,000
|
$500
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells
|
ZIA BC 011224
|
$236,167
|
$236,167
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
West Coast AIDS and Cancer Specimen Resource (ACSR)
|
5U01CA066529-16
|
$1,206,433
|
$301,608
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Viral Oncology Training Grant
|
5T32CA009111-33
|
$296,458
|
$29,646
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral and cellular gene regulation during lytic KSHV replication
|
5R01CA119905-05
|
$222,788
|
$111,394
|
Swaminathan, Sankar
|
UNIVERSITY OF FLORIDA
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-06
|
$254,023
|
$254,023
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$2,020
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$2,978
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$95,910
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$95,987
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$66,250
|
$66,250
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$2,998
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$2,220
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$2,970
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$193,923
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S6
|
$1,444,105
|
$86,646
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S7
|
$98,815
|
$5,929
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$59,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-03S1
|
$91,667
|
$2,750
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-03
|
$1,463,613
|
$43,908
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding the mechanism of KSHV latent DNA replication
|
5R00CA126182-04
|
$249,000
|
$249,000
|
Verma, Subhash
|
UNIVERSITY OF NEVADA RENO
|
|
Uganda-UCSF Research Training in HIV-Associated Malignancies
|
1D43CA153717-01
|
$500,900
|
$500,900
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Tumor and Metastasis Therapy
|
ZIA BC 011024
|
$595,307
|
$476,246
|
Khanna, Chand
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$595,307
|
$595,307
|
Khanna, Chand
|
CCR (NCI)
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-19
|
$323,606
|
$100,318
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis
|
5K08CA138764-02
|
$179,280
|
$179,280
|
Jones, Kevin
|
UNIVERSITY OF UTAH
|
|
Training in Tumor Virology
|
5T32CA115299-05
|
$269,835
|
$53,967
|
Robertson, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-09
|
$234,840
|
$234,840
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-14
|
$246,768
|
$12,338
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$456,762
|
$91,352
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Third International Chordoma Research Workshop: Catalyzing New Advances in Chordo
|
1R13CA153794-01
|
$10,000
|
$10,000
|
Les, Edward
|
CHORDOMA FOUNDATION
|
|
Therapeutic Targets in Alveolar Rhabdomyosarcoma
|
7R01CA133229-04
|
$145,134
|
$145,134
|
KELLER, CHARLES
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Therapeutic Targets in Alveolar Rhabdomyosarcoma
|
5R01CA133229-03
|
$168,187
|
$168,187
|
KELLER, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
2P50CA086306-11
|
$1,897,432
|
$341,538
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
THE ROLE OF THE INTERFERONS IN CANCER IMMUNOEDITING
|
2R01CA043059-22
|
$380,000
|
$380,000
|
SCHREIBER, ROBERT
|
WASHINGTON UNIVERSITY
|
|
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis
|
5K08CA132986-02
|
$169,884
|
$169,884
|
MATUSHANSKY, IGOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Molecular Actions of Imatinib Mesylate in GISTs
|
5R01CA106588-07
|
$433,446
|
$433,446
|
GODWIN, ANDREW
|
FOX CHASE CANCER CENTER
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$207,153
|
$10,358
|
Caplen, Natasha
|
CCR (NCI)
|
|
The East Coast AIDS and Cancer Specimen Resource
|
5U01CA066535-16
|
$1,031,638
|
$257,910
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
The ARF Tumor Suppressor
|
1R01CA139319-01A1
|
$362,088
|
$90,522
|
MURPHY, MAUREEN
|
FOX CHASE CANCER CENTER
|
|
The 13th international Workshop on KSHV and Related Agents
|
1R13CA153946-01
|
$12,000
|
$12,000
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Targeting EWS/FLI1-driven pathways to improve therapeutic gains in Ewing's Sarcom
|
5R01CA134727-03
|
$318,513
|
$318,513
|
NOTARIO, VICENTE
|
GEORGETOWN UNIVERSITY
|
|
Targeting Entry of Retroviral/Lentiviral Vectors
|
5R01CA049932-18
|
$286,425
|
$286,425
|
ROTH, MONICA
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
5R01CA136912-02
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Studying the role of KSHV-encoded microRNAs
|
5R01CA119917-03
|
$297,147
|
$297,147
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
Total relevant funding to Sarcoma for this search: $59,551,724
|